
Human Papillomavirus (HPV) infection is the most common sexually transmitted viral infection in the world. Persistent infection lasting more than two years, particularly with High-Risk (HR) HPV genotypes, can lead to malignant transformation. Estimating HPV prevalence among high-risk men in Sri Lanka...

Since its emergence in 2019, SARS-CoV-2 has shown remarkable evolutionary plasticity, profoundly shaping the course of the COVID-19 pandemic. This review summarizes key evolutionary milestones from 2019 to 2025, highlighting mechanisms such as point mutations, positive selection, recombination, and evolution...

Dolutegravir (DTG) is an integrase strand transfer inhibitor indicated for human immunodeficiency virus (HIV) infection. Although intrinsic factors show no ethnic-specific impact on DTG pharmacokinetics, extrinsic factors may modulate its pharmacokinetic profile. This study developed a population pharmacokinetic...

Among the wide variety of antivirals that have been developed for the treatment of human immunodeficiency virus (HIV) infections and acquired immunodeficiency syndrome (AIDS), two stand out: tenofovir and rilpivirine. The names unmistakenly associated with the discovery of these two compounds, are Antonín...